Københavns Universitet Nørregade 10 Copenhagen K 1017 Caroline Volf +45 35333391 caroline.volf@adm.ku.dk www.oko.ku.dk university Acquisition of three Evosep One instruments to Proteomics Program at the Novo Nordisk Foundation Center for Protein Research. 043-0290-17-7000 The procurement is a purchase of a new and unique equipment related to a clinical proteomics research group at University of Copenhagen. 1553200.00 The primary focus at the Novo Nordisk Foundation Center for Protein Research is basic research within protein-related areas, including protein signaling and pathways, protein structure, disease systems biology and particularly technological developments within mass spectrometry-based proteomics. The procured equipment will be used for research and development, in a clinical context for identification of human proteins of medical relevance. The equipment will be used for clinical analysis of blood samples, which in a medical context requires high-throughput (up to 300 samples/day) and high sensitivity. According to the European Parliament and Council Directive No. 2014/24/ EC, Article 32. 2, point b, the University of Copenhagen believes that other supplier is able to provide analytical LC equipment with similar specifications for high-throughput, low-flow and sensitive analysis of complex peptide samples as an integrated LC-MS solution. The unique features of the relevant equipment are: Use of disposable trap columns: — Reduces carry-over in e.g. complex HeLa digests to < 0.05 % of TIC. — Reduces cycle time (<5min per sample). Partial elution from trap columns: — Leaves impurities on the disposable traps, thereby greatly increasing column life. Gradient offset focusing (where the organic %B-gradient is lowered concurrently with the elution and pre-separation of peptides in a pre-formed gradient): — Allows shorter columns / improves resolving power on analytical column. Fast trap-elution and gradient formation at 30μl/min. Use of a long and narrow storage loop as hand-over between the low-pressure, high-flow gradient preparation and the high-pressure, low-flow gradient delivery. Optimized high-throughput capabilities: — Up to 300 samples/day @ 1-2 μl/min flow rate — Up to 93 % MS utilization rate Only Evosep Bioscience can provide an integrated solution that allows high-throughput of complex peptide samples (up to 300 samples/day) and ensures high utilization rate of the MS instrumentation (up to 93 %). No other supplier can provide an integrated LC-MS solution that allows similar throughput. The purchaser needs a system that allow for analysis of several hundreds of clinically relevant peptide mixtures per day per MS instrument, and the requirement for a system able to integrative and automatically handle sample injection and chromatographic peptide separation in a short time-frame is of the utmost importance. In order to analyze up to 300 samples per day by MS specifically requires that loading of sample and chromatographic separation of peptide mixtures by reverse-phase chromatography are handled within 5 minutes per individual sample (total run time). This in turn ensures high utilization of MS instrumentation, and only hereby enables high-throughput analyses. 2017-11-28 Evosep Biosystems Thriges Plads 6 Odense C 5000 +45 26332021 info@evosep.com http://www.evosep.com 1553200.00 Klagenævnet for Udbud Dahlerups Pakhus, Langelinie Allé 17 København Ø 2100 +45 35291000 klfu@erst.dk http://www.klfu.dk Precise information on deadline(s) for lodging appeals: A complaint against the contracting entity who, in accordance with the European Parliament and Council Directive No. 2014/24/EC, Article 32, has decided to award a contract without prior publication of a contract notice in the Official Journal of the European Union must,in accordance with the Danish act on enforcement of procurement rules, etc. § 7, para. 3, be filed to the Danish Public procurement Appeal Board within 30 calendar days from the day following the day on which a contract notice is published in the Official Journal of the European Union. The Danish act on enforcement of procurement rules, etc. defines in § 2, para. 2, point 1, a standstill period of 10 calendar days from the day after the date on which the voluntary ex ante transparency notice is published in the Official Journal of the European Union. Latest at the same time as a complaint is lodged to the Danish Public procurement Appeal Board, the appellant shall in writing inform the contracting entity about the lodging of a complaint to the Danish Public procurement Appeal Board, and whether the complaint has been submitted in the stand still period. In cases where the complaint is not submitted in the stand still period, the appellant must specify any suspensive effect of the complaint according to The Danish act on enforcement of procurement rules § 12, Para. 1. Kokurrence- og Forbrugerstyrelsen Carl Jacobsens Vej 35 Valby 2500 +45 41715000 kfst@kfst.dk http://www.kfst.dk 2017-11-28
See tender at TED: http://ted.europa.eu/udl?uri=TED:NOTICE:480287-2017:TEXT:EN:HTML